An observational study he cites saw no significant gap in major adverse liver outcomes between the two drugs over 17 months.
Recap by typeshit. Post by Scott Isaacs on X.
The REDEFINE 1 data covered 2,309 women, with placebo at 3%. In the REDEFINE 4 head-to-head, tirzepatide matched or slightly beat it.
Superpower says the drug carries radiation straight to cancer cells and cites a phase 3 trial showing a 79% lower risk of progression or death. A 14-part thread.
Australian experts note about half a million people there use GLP-1 drugs for diabetes alone, and lay out what new users should keep in mind about nutrition.
A herpetology-themed clip from PBS points to reptiles as part of the story behind today's GLP-1 medications. Short and light, but a fun bit of history.
Ashlee Amborn says she conceived a month after starting a GLP-1. A Maven Clinic doctor advises stopping the drug about two months before trying.
In a small 39-person, four month trial, both support groups regained about 3.6% of weight versus 10.75% for usual care, per Obesity Science & Practice.
Loading…